#news #biotech Gene therapy hemophilia B ‘cure’ approach heats up as uniQure/CSL, rivalling Pfizer, shows promise

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gene therapy hemophilia B ‘cure’ approach heats up as uniQure/CSL, rivalling Pfizer, shows promise .Gene therapy hemophilia B ‘cure’ approach heats up as uniQure/CSL, rivalling Pfizer, shows promise
badams
Thu, 11/19/2020 – 10:38

from FierceBiotech: Biotech https://ift.tt/3pIt8g9